Pfizer Korea wins Lyrica patent suit

The Korean Intellectual Property Tribunal has ruled in favor of Pfizer Korea in a patent nullification suit involving Pfizer’s use patent covering Lyrica (pregabalin).

Lyrica is used to treat chronic pain disorders like fibromyalgia and other neuropathic pain disorders.

Ten domestic pharmaceutical companies, including CJ Pharm, Hanmi Pharm and Dong-A Pharm, filed a lawsuit for the nullif...